NCAA Moves to End Marijuana Ban, Study Finds Mexican Cartels a Major Employer, More... (9/25/23)

A pair of Republican senators file a bill to require congressional approval to down-schedule marijuana, the House Rules Committee advances a pair of psychedelic research amendments to the defense spending bill, and more.

Marijuana Policy

GOP Senators File Bill to Block Marijuana Legalization Without Congressional Approval. Last Friday, Sen. Cynthia Lummis (R-WY), joined by her colleague Sen. Steve Daines (R-MT), introduced the Deferring Executive Authority (DEA) Act to give Congress final approval over the legalization of marijuana. 

According to a recent report from the Congressional Research Service, the Drug Enforcement Administration (DEA) has signaled it will follow a recommendation issued by the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to transfer marijuana from Schedule I to Schedule III under the Controlled Substances Act. This would, in essence, legalize marijuana federally. 

This recommendation was issued after President Biden requested that the Department of Justice (DOJ) and HHS evaluate marijuana’s status as a Schedule I substance.  The Deferring Executive Authority (DEA) Act will require congressional review of rules rescheduling marijuana. 

"Congress makes the laws in this country, not DC bureaucrats," said Lummis. "The American people through their elected representatives in the Senate and House should have the final say on such a momentous change as the legalization of marijuana. The Biden administration’s rush to reschedule marijuana without compelling scientific evidence appears to be political, not about what’s best for the American people."  

NCAA Committee Recommends Legislation to Remove Marijuana from Banned Substances List in All Three Divisions. The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports recommended legislation that would remove marijuana from the NCAA's list of banned drug classes at all three divisions, the organization announced last Friday. The recommendation calls for a "robust educational strategy" for college athletes when it comes to marijuana.

"Cannabis is not a performance-enhancing drug and that a harm-reduction approach to cannabis is best implemented at the school level," the NCAA said in a statement following midweek meetings in Indianapolis. 

The committee reasoned that removing marijuana from the list of banned substances achieves several aims: acknowledging the ineffectiveness of the current policy of banning, testing, and penalizing; affirming that NCAA drug testing is aimed only at performance-enhancing substances; and emphasizes the importance of moving toward a harm reduction strategy.

The recommendation now goes to the governing structures of the NCAA's three divisions.

"When making a decision on an important topic like this, we agree that the membership should have an opportunity to vote on the final outcome," committee chair James Houle, lead sport psychologist at Ohio State, said in a statement. "We are recommending a big shift in the paradigm when it comes to cannabinoids. We want to modernize the strategy with the most up-to-date research to give schools the best opportunity to support the health of student-athletes."

Psychedelics

House Rules Committee Clears Pair of Psychedelic Research Amendments to Defense Spending Bill. The House Rules Committee last Saturday approved two psychedelic research amendments for inclusion in the must-pass defense spending bill. It also cleared the larger defense bill for a House floor vote this as a government spending deadline looms.

One amendment, sponsored by Reps. Morgan Luttrell (R-TX) and Dan Crenshaw (R-TX), would provide $15 million in funding for DOD to carry out "Psychedelic Medical Clinical Trials."

The other amendment, also from Crenshaw, would require the Defense Health Agency to "submit a report to Congress on options to ensure that active-duty service members who are suffering from Traumatic Brain Injuries (TBI) and Post-Traumatic Stress Disorder (PTSD) are able to participate in clinical trials under the Department of Veterans Affairs for the purposes of studying the effectiveness of psychedelic substances."

International

Mexican Drug Cartels Employ 175,000 People, Study Finds. Mexican drug trafficking organizations—the so-called cartels—employ roughly 175,000 people, according to new research findings published in the journal Science. That makes organized crime the fifth-largest employment sector in the country. 

The study examined a decade of data on murders, missing persons, and imprisoned people and used a mathematical model to determine overall cartel membership and which policy responses would best reduce violence. Homicides in the country have tripled since 2007, when then-President Felipe Calderon escalated the domestic drug war by sending in the army.

The study authors argue that the best way to reduce violence is not to lock up more gang members, which they argue would actually increase the murder rate, but to cut cartel recruitment.

"More than 1.7 million people in Latin America are incarcerated, and adding more people to saturated jails will not solve the insecurity problem," wrote the authors.

The analysts identified 198 armed criminal groups in the country, although two of them, the Sinaloa cartel and the Jalisco New Generation cartel, battle for national domination.